nodes	percent_of_prediction	percent_of_DWPC	metapath
Anileridine—Fentanyl—Benzphetamine—obesity	0.752	1	CrCrCtD
Anileridine—Loperamide—POMC—obesity	0.00299	0.322	CrCbGaD
Anileridine—Haloperidol—DRD4—obesity	0.00129	0.139	CrCbGaD
Anileridine—Haloperidol—HTR1B—obesity	0.00115	0.124	CrCbGaD
Anileridine—Haloperidol—DRD1—obesity	0.0011	0.118	CrCbGaD
Anileridine—Pethidine—SLC6A4—obesity	0.000908	0.0978	CrCbGaD
Anileridine—Haloperidol—DRD2—obesity	0.000773	0.0832	CrCbGaD
Anileridine—Haloperidol—HTR2A—obesity	0.000597	0.0643	CrCbGaD
Anileridine—Pethidine—ALB—obesity	0.000478	0.0514	CrCbGaD
Anileridine—OPRM1—GPCR downstream signaling—PMCH—obesity	0.000419	0.00175	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—NPY5R—obesity	0.000419	0.00175	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—obesity	0.000412	0.00172	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—MKS1—obesity	0.00041	0.00171	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—KIF7—obesity	0.00041	0.00171	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—NPS—obesity	0.000408	0.00171	CbGpPWpGaD
Anileridine—OPRM1—G alpha (i) signalling events—C3—obesity	0.000405	0.00169	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—TGFB1—obesity	0.000402	0.00168	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—MC4R—obesity	0.000401	0.00168	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—MC3R—obesity	0.000401	0.00168	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—NPY2R—obesity	0.000401	0.00168	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—NPY1R—obesity	0.000401	0.00168	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—HTR2C—obesity	0.0004	0.00167	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—DRD1—obesity	0.0004	0.00167	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PPY—obesity	0.000394	0.00165	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—ADRB1—obesity	0.000388	0.00162	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—GIP—obesity	0.000386	0.00162	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PRKCH—obesity	0.000386	0.00162	CbGpPWpGaD
Anileridine—OPRM1—G alpha (i) signalling events—AGT—obesity	0.000385	0.00161	CbGpPWpGaD
Anileridine—OPRM1—Peptide ligand-binding receptors—POMC—obesity	0.000384	0.0016	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—HCRT—obesity	0.00038	0.00159	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PMCH—obesity	0.00038	0.00159	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—NMU—obesity	0.00038	0.00159	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—NPY5R—obesity	0.00038	0.00159	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—GHRL—obesity	0.000379	0.00159	CbGpPWpGaD
Anileridine—OPRM1—IL4-mediated signaling events—AKT1—obesity	0.000377	0.00158	CbGpPWpGaD
Anileridine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—obesity	0.000376	0.00157	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—DRD4—obesity	0.000376	0.00157	CbGpPWpGaD
Anileridine—OPRM1—Peptide ligand-binding receptors—CCL2—obesity	0.000376	0.00157	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PRLH—obesity	0.000375	0.00157	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—obesity	0.000366	0.00153	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—MC3R—obesity	0.000365	0.00152	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—MC4R—obesity	0.000365	0.00152	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—NPY1R—obesity	0.000365	0.00152	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—NPY2R—obesity	0.000365	0.00152	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CNR1—obesity	0.000359	0.0015	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PPY—obesity	0.000358	0.00149	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PRKCH—obesity	0.000351	0.00147	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—GIP—obesity	0.000351	0.00147	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—DRD2—obesity	0.00035	0.00146	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—GCG—obesity	0.000347	0.00145	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—ADRB3—obesity	0.000329	0.00137	CbGpPWpGaD
Anileridine—OPRM1—G alpha (i) signalling events—POMC—obesity	0.000324	0.00135	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—obesity	0.000322	0.00135	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—C3—obesity	0.000322	0.00135	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—GAL—obesity	0.000321	0.00134	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—C5AR1—obesity	0.000317	0.00133	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—ADRB2—obesity	0.000314	0.00131	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NMB—obesity	0.000311	0.0013	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—GHRH—obesity	0.000311	0.0013	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGT—obesity	0.000306	0.00128	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—IL6—obesity	0.000303	0.00127	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—GNB3—obesity	0.000299	0.00125	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—ADRB3—obesity	0.000298	0.00125	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—FFAR4—obesity	0.000296	0.00124	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—GAL—obesity	0.000291	0.00122	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—GNAS—obesity	0.000291	0.00122	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CCK—obesity	0.00029	0.00121	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—C5AR1—obesity	0.000288	0.0012	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—MCHR1—obesity	0.000284	0.00119	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—BRS3—obesity	0.000284	0.00119	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—GHSR—obesity	0.000284	0.00119	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—GLP1R—obesity	0.000283	0.00118	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—F2—obesity	0.000283	0.00118	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—AKT1—obesity	0.00028	0.00117	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CCL5—obesity	0.000278	0.00116	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CCKAR—obesity	0.000278	0.00116	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—HRH3—obesity	0.000278	0.00116	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SH2B1—obesity	0.000264	0.0011	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PRLHR—obesity	0.000264	0.0011	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—GH1—obesity	0.000264	0.0011	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCK—obesity	0.000264	0.0011	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—obesity	0.000257	0.00108	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—GLP1R—obesity	0.000257	0.00107	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—HRH3—obesity	0.000253	0.00106	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCKAR—obesity	0.000253	0.00106	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—NPY—obesity	0.000252	0.00105	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—obesity	0.000252	0.00105	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—IAPP—obesity	0.000251	0.00105	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PYY—obesity	0.000248	0.00104	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—APLN—obesity	0.000248	0.00104	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—HTR2A—obesity	0.000245	0.00103	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—C3—obesity	0.000245	0.00102	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PRKAR2B—obesity	0.000243	0.00102	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CRH—obesity	0.000243	0.00102	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—HTR1B—obesity	0.000243	0.00102	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PNLIP—obesity	0.000235	0.000984	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—AGT—obesity	0.000233	0.000974	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—NPS—obesity	0.000231	0.000964	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SDC3—obesity	0.00023	0.000961	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—NPY—obesity	0.000229	0.000957	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—IAPP—obesity	0.000228	0.000951	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—HTR2C—obesity	0.000226	0.000945	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—DRD1—obesity	0.000226	0.000945	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NPY5R—obesity	0.000225	0.000939	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NMU—obesity	0.000225	0.000939	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HCRT—obesity	0.000225	0.000939	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PMCH—obesity	0.000225	0.000939	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—HTR1B—obesity	0.000221	0.000923	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CRH—obesity	0.000221	0.000923	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—ADRB1—obesity	0.000219	0.000915	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NPY2R—obesity	0.000215	0.0009	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—MC4R—obesity	0.000215	0.0009	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—MC3R—obesity	0.000215	0.0009	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NPY1R—obesity	0.000215	0.0009	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—F2—obesity	0.000215	0.0009	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—GHRL—obesity	0.000214	0.000896	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—DRD4—obesity	0.000213	0.000889	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PPY—obesity	0.000211	0.000883	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—NPS—obesity	0.000209	0.000875	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HDAC8—obesity	0.000207	0.000867	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PRKCH—obesity	0.000207	0.000867	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—GIP—obesity	0.000207	0.000867	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—HTR2C—obesity	0.000205	0.000858	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—DRD1—obesity	0.000205	0.000858	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CNR1—obesity	0.000203	0.000849	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—ADRB1—obesity	0.000199	0.000831	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—DRD2—obesity	0.000198	0.000828	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—LEPR—obesity	0.000197	0.000823	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—GCG—obesity	0.000196	0.00082	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—POMC—obesity	0.000196	0.000819	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—GHRL—obesity	0.000195	0.000814	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—DRD4—obesity	0.000193	0.000807	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CCL2—obesity	0.000192	0.000802	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CNR1—obesity	0.000184	0.000771	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—DRD2—obesity	0.00018	0.000752	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—GCG—obesity	0.000178	0.000744	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—ADRB2—obesity	0.000177	0.000742	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—ADRB3—obesity	0.000176	0.000737	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—GAL—obesity	0.000172	0.00072	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—C5AR1—obesity	0.00017	0.000712	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—GNB3—obesity	0.000169	0.000706	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—GNAS—obesity	0.000165	0.000688	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—ADRB2—obesity	0.000161	0.000674	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CCL5—obesity	0.000157	0.000658	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PRKG1—obesity	0.000156	0.000651	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCK—obesity	0.000156	0.000651	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—GNB3—obesity	0.000153	0.000641	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—RBP4—obesity	0.000152	0.000634	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—GLP1R—obesity	0.000152	0.000634	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—GNAS—obesity	0.000149	0.000625	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCKAR—obesity	0.000149	0.000624	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HRH3—obesity	0.000149	0.000624	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PRKAR2B—obesity	0.000144	0.000601	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCL5—obesity	0.000143	0.000597	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PRKCD—obesity	0.000142	0.000593	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NCF2—obesity	0.000139	0.00058	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—HTR2A—obesity	0.000139	0.00058	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—C3—obesity	0.000139	0.000579	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NPY—obesity	0.000135	0.000565	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—APOC3—obesity	0.000134	0.000562	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—IAPP—obesity	0.000134	0.000562	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—AGT—obesity	0.000132	0.00055	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CRH—obesity	0.00013	0.000545	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HTR1B—obesity	0.00013	0.000545	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SDC1—obesity	0.000129	0.000539	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PRKCD—obesity	0.000129	0.000538	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—AKR1C3—obesity	0.000127	0.000531	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—HTR2A—obesity	0.000126	0.000527	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—C3—obesity	0.000126	0.000526	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NPS—obesity	0.000124	0.000517	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—F2—obesity	0.000122	0.000508	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PRKCB—obesity	0.000122	0.000508	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HTR2C—obesity	0.000121	0.000507	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—DRD1—obesity	0.000121	0.000507	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—AGT—obesity	0.00012	0.0005	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NTRK2—obesity	0.000118	0.000493	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—ADRB1—obesity	0.000117	0.000491	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PIK3CG—obesity	0.000116	0.000486	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—GHRL—obesity	0.000115	0.000481	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PARP1—obesity	0.000115	0.000481	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—DRD4—obesity	0.000114	0.000477	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—POMC—obesity	0.000111	0.000463	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PRKCB—obesity	0.00011	0.000462	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—F2—obesity	0.00011	0.000462	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CNR1—obesity	0.000109	0.000455	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—TCF7L2—obesity	0.000107	0.000447	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—AKT2—obesity	0.000106	0.000445	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—DRD2—obesity	0.000106	0.000444	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PIK3CG—obesity	0.000106	0.000442	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PTPN1—obesity	0.000105	0.00044	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—GCG—obesity	0.000105	0.00044	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PIK3CD—obesity	0.000102	0.000428	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—POMC—obesity	0.000101	0.000421	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PRL—obesity	0.0001	0.000419	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—STK11—obesity	9.89e-05	0.000413	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCL2—obesity	9.84e-05	0.000411	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PLG—obesity	9.78e-05	0.000409	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—RHOA—obesity	9.76e-05	0.000408	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—AKT2—obesity	9.67e-05	0.000404	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PIK3R1—obesity	9.66e-05	0.000404	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—FOXO3—obesity	9.54e-05	0.000399	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—ADRB2—obesity	9.52e-05	0.000398	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SOCS1—obesity	9.37e-05	0.000392	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PIK3CD—obesity	9.29e-05	0.000388	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SOCS3—obesity	9.26e-05	0.000387	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—GNB3—obesity	9.06e-05	0.000379	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—TYK2—obesity	8.94e-05	0.000374	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PIK3CB—obesity	8.92e-05	0.000373	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—IGF2—obesity	8.9e-05	0.000372	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—RHOA—obesity	8.86e-05	0.000371	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—GNAS—obesity	8.83e-05	0.000369	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PIK3R1—obesity	8.77e-05	0.000367	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—APOB—obesity	8.64e-05	0.000361	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCL5—obesity	8.44e-05	0.000353	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—LPL—obesity	8.25e-05	0.000345	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—FOXO1—obesity	8.19e-05	0.000343	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—RPS6KB1—obesity	8.18e-05	0.000342	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PIK3CB—obesity	8.1e-05	0.000339	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PRKCD—obesity	7.6e-05	0.000318	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HTR2A—obesity	7.44e-05	0.000311	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—C3—obesity	7.43e-05	0.000311	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—IRS2—obesity	7.07e-05	0.000295	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—AGT—obesity	7.06e-05	0.000295	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—LEP—obesity	6.92e-05	0.000289	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—APOE—obesity	6.92e-05	0.000289	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CAV1—obesity	6.85e-05	0.000287	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—APOA1—obesity	6.84e-05	0.000286	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—ESR1—obesity	6.6e-05	0.000276	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—F2—obesity	6.52e-05	0.000273	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PRKCB—obesity	6.52e-05	0.000273	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—BAD—obesity	6.45e-05	0.000269	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PIK3CG—obesity	6.24e-05	0.000261	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—IRS1—obesity	6.17e-05	0.000258	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—POMC—obesity	5.94e-05	0.000248	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—INS—obesity	5.91e-05	0.000247	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCL2—obesity	5.81e-05	0.000243	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—IGF1—obesity	5.72e-05	0.000239	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—AKT2—obesity	5.71e-05	0.000239	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PIK3CD—obesity	5.49e-05	0.000229	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PIK3CA—obesity	5.44e-05	0.000227	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SERPINE1—obesity	5.43e-05	0.000227	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—TYK2—obesity	5.28e-05	0.000221	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—RHOA—obesity	5.24e-05	0.000219	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NOS3—obesity	5.18e-05	0.000217	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PIK3R1—obesity	5.18e-05	0.000217	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PIK3CA—obesity	4.94e-05	0.000206	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—MTOR—obesity	4.78e-05	0.0002	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PIK3CB—obesity	4.78e-05	0.0002	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—AKT1—obesity	4.44e-05	0.000186	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—IL6—obesity	4.37e-05	0.000183	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—MMP9—obesity	4.16e-05	0.000174	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—MAPK8—obesity	4.04e-05	0.000169	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—AKT1—obesity	4.03e-05	0.000169	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—STAT3—obesity	3.7e-05	0.000155	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—MYC—obesity	3.44e-05	0.000144	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—TGFB1—obesity	3.43e-05	0.000143	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PIK3CA—obesity	2.92e-05	0.000122	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—IL6—obesity	2.58e-05	0.000108	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—AKT1—obesity	2.38e-05	9.96e-05	CbGpPWpGaD
